New Delhi: Union defence minister Rajnath Singh and health minister Dr Harsh Vardhan on Monday released the first batch of Anti-Covid drug 2DG developed by the Defence Research and Development Organisation (DRDO).
Dr Vardhan said that the Anti-Covid drug 2DG may be our first indigenous research-based outcome to fight against Covid-19. It will reduce recovery time and oxygen dependency,” Vardhan.
He further added, “Not just for India but I hope it serves in the fight against Covid, globally in the coming days. I thank and congratulate DRDO and its scientists.” he added.
The Drugs Controller General of India (DGCI) approved the oral drug for emergency use as an adjunct therapy in moderate to severe coronavirus patients.
Earlier on May 8, the defence ministry said the clinical trials of the drug, 2-deoxy-D-glucose (2-DG), showed that it helps in a faster recovery of hospitalised patients and reduces supplemental oxygen dependence.
Discussion about this post